Treatment guidelines for patients with thyroid nodules and well- differentiated thyroid cancer

Archives of Internal Medicine

Volumn 156, Issue 19, 1996, Pages 2165-2172

  Singer, Peter A ^a,l   Cooper, David S ^b,c   Daniels, Gilbert H ^d   Ladenson, Paul W ^b   Greenspan, Francis S ^e   Levy, Elliot G ^f   Braverman, Lewis E ^g   Clark, Orlo H ^h   McDougall, I Ross ⁱ   Ain, Kenneth V ^j   Dorfman, Steven G ^k  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF KENTUCKY   (United States)

^k Endocrine Associates of Dallas   (United States)

^l NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; THYROGLOBULIN;

ASPIRATION BIOPSY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; ECHOGRAPHY; FOLLOW UP; GOITER; LABORATORY DIAGNOSIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; TREATMENT PLANNING;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; HUMANS; IODINE RADIOISOTOPES; LYMPHOMA, NON-HODGKIN; PHYSICAL EXAMINATION; THYROID FUNCTION TESTS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

EID: 16044368318     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.19.2165     Document Type: Review

References (21)

1. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559.
2. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term follow up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery. 1989;106:980-986.
3. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
4. Ross D. Thyroid hormone suppressive therapy of sporadic nontoxic goiter. Thyroid. 1992;2: 263-269.
5. Cooper DS. Thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab. 1995;80:331-334.
6. Huysmans DAKC, Hermus Ad RMM, Constens FHM, Barentsz JO, Klopperborg PWC. Large, compressive goiters treated with radioiodine. Ann Intern Med. 1994;121:757-762.
7. Dulgeroff AJ, Hershman JM. Medical therapy for differentiated thyroid carcinoma. Endocr Rev. 1994; 15:500-515.
8. DeGroot LJ, Kaplan EL, McMormick M, Strauss FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424.
9. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 1990;19:545-576.
10. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97:418-428.
11. Mazzaferri EL, Young RL Papillary thyroid carcinoma: a 10 year follow up report of the impact of therapy in 576 patients. Am J Med. 1981; 70:511-518.
12. Wartofsky L. Use of sensitive TSH assay to determine thyroid hormone therapy, avoid osteoporosis. Annu Rev Med. 1991;42:341-345.
13. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long-term thyrotropin suppression with levothyroxine. J Clin Endocrinol Metab. 1993; 77:334-338.
14. Barsano CP, Skosey C, DeGroot LJ, Refetoff S. Serum thyroglobulin in the management of patients with thyroid cancer. Arch Intern Med. 1982; 142:763-767.
15. Ozata M, Suzuki S, Miyamoto T, Liu TR, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the follow up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab. 1994; 79:98-105.
16. Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med. 1980; 21:733-737.
17. Simpson WJ, Panzarella T, Caruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1988;14: 1063-1075.
18. Moley JF. Medullary thyroid cancer. Surg Clin North Am. 1995;75:405-420.
19. Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF. Applications of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am. 1996;25:1-25.
20. Nel CJC, van Heerden JA, Goellner JR, et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc. 1985; 60:51-58.
21. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3:93-98.